ArticleThe Journal of antimicrobial chemotherapy2015

HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavir.

K A Sutherland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.